Clostridium Botulinum Toxin Type A
Product details
Active ingredients | Clostridium Botulinum Toxin Type A |
Application part | Face, neck |
Duration | 6 months |
Appearance | It appears as a white to yellowish, vacuum-dried powder for injection in a colorless and transparent vial. It should become colorless transparent liquid when dissolved in the diluent (physiological saline solution). |
Packing unit | 1 vial |
Country of origin | Republic of Korea |
Description
Nabota Daewoong is a South Korean preparation for combating expression lines. It is a muscle relaxant of peripheral action, an analogue of alternative Botulinum Toxins. The product is based on botulinum toxin type A. It is a poisonous substance produced by the bacteria Clostridium botulinum. It is intended for denervation of muscle tissue in case of uncontrolled muscle tone or active facial expressions.
This is a botulinum toxin wrinkle remover that received FDA approval in early January. Nabota is the first South Korean botulinum toxin (BTX) to enter the US market.
Application of Nabota
- Nasolabial folds
- Glabellar folds
- Periorbital zone
- Periorbital zone
- Normalizes sweating of palms and armpits with hyperhidrosis.
Benefits of Nabota
- Differs in a high level of security.
- Does not “freeze” facial expressions.
- Acts quickly.
- The resulting effect lasts for at least six months.
Procedure
Dilute 100 U / 2.5 ml (4 U / 0.1 ml) with 0.9% sterile saline without preservative.
Using a 30-gauge injection needle, inject the drug.
Nabota effect
The therapeutic effect of NSAIDs on wrinkles lasts about 3-4 months.
Nabota peculiar properties:
Nabota’s drying process during manufacturing is done through vacuum-drying, an updated technique that leaves almost none of powder at the bottom of the vial. That provides a non-heat sensitive final product and minimizes denaturalization when diluted.